Oracle Corporation’s stock is navigating turbulent trading sessions. A recent media report alleging delays in a critical OpenAI project injected fresh volatility on Friday, compounding existing investor unease following the company’s latest quarterly results. Despite swift management rebuttals, a sell-off ensued, highlighting growing market skepticism about the aggressive timeline for its artificial intelligence infrastructure expansion.
Record Contracts and Mounting Capital Demands
The current volatility follows Oracle’s recent financial disclosure, which presented a complex picture. The software giant reported an explosive surge in its remaining performance obligations (RPO), which soared to a record $523 billion. This growth is primarily fueled by massive cloud contracts with AI leaders, including Nvidia and Meta.
However, fulfilling these commitments requires immense upfront investment. Oracle has significantly raised its capital expenditure (CapEx) forecast to $50 billion. These substantial outlays pressured its free cash flow deeply into negative territory last quarter, a development that has drawn scrutiny from financial analysts. The central question emerging on Wall Street is the timeline for converting this enormous backlog into profitable revenue.
A Denial Fails to Stem the Selling Pressure
The immediate catalyst for Friday’s decline was a Bloomberg report suggesting the completion of a planned data center for OpenAI could be delayed until 2028, citing supply chain and labor constraints. Oracle promptly issued a denial, stating no such delays exist and that all project milestones remain on schedule.
Should investors sell immediately? Or is it worth buying Oracle?
The market’s reaction, however, was pronounced. Oracle’s equity closed the session down 4.67 percent at €161.44. The sell-off indicates deep-seated investor apprehension about execution risks associated with the company’s massive physical infrastructure build-out.
Diverging Analyst Views on Valuation and Strategy
This episode reflects broader doubts about the near-term payoff from AI investments. Oracle’s stock has undergone a significant valuation correction, now trading more than 42 percent below its 52-week high.
Expert commentary is divided. Some market strategists have lowered their price targets, citing the high capital intensity and potential for deferred revenue recognition. Others view the current financial pressures as a necessary cost of securing long-term dominance in the competitive cloud sector.
For shareholders, the coming quarters will be critical in assessing Oracle’s ability to advance its infrastructure expansion without further margin erosion. Income-focused investors are looking ahead to January 9, 2026, the key date for the company’s next quarterly dividend distribution.
Ad
Oracle Stock: Buy or Sell?! New Oracle Analysis from December 14 delivers the answer:
The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 14.
Oracle: Buy or sell? Read more here...











